Lidocaine and Plendil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lidocaine (lidocaine) and Plendil (felodipine). Common drug interactions include arthralgia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Lidocaine and Plendil. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lidocaine?

Lidocaine has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 27,555 Lidocaine users. Check the latest studies of Lidocaine.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.



On Jul, 19, 2026

18 people who take Lidocaine and Plendil together, and have interactions are studied.

Lidocaine and Plendil drug interactions.

What are the common drug interactions of Lidocaine and Plendil, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Atrophy (wasting away of a part of the body)
  3. Dry skin
  4. Exfoliative rash (scaly red generalized skin rash)
  5. Gait disturbance
  6. Joint contracture (a permanent shortening of a muscle or joint)
  7. Joint range of motion decreased (disease of joint movement)
  8. Joint stiffness
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Myalgia (muscle pain)

male:

  1. Renal failure (kidney dysfunction)
  2. Coagulation factor deficiency (lack of clotting substance in blood)
  3. Acute stress disorder
  4. Blood alkaline phosphatase increased
  5. Gamma-glutamyltransferase increased
  6. Nausea (feeling of having an urge to vomit)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Emotional distress
  10. Fear

What are the common drug interactions of Lidocaine and Plendil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Generalised oedema (swelling all over the body)
  2. Stress
  3. Finger deformity (a deformed position of the finger)
  4. Muscular weakness (muscle weakness)
  5. Skin induration (an abnormally hard spot or area on the skin)
  6. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  7. Drug toxicity
  8. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  9. Hand deformity
  10. Muscle contracture (a permanent shortening of a muscle)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Death
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Renal failure (kidney dysfunction)
  9. Renal impairment (severely reduced kidney function)
  10. Renal injury (kidney injury)

50-59:

  1. Coagulation factor deficiency (lack of clotting substance in blood)
  2. Haemorrhage (bleeding)
  3. Heparin-induced thrombocytopenia
  4. Pyrexia (fever)
  5. Renal failure (kidney dysfunction)
  6. Decreased appetite
  7. Diarrhoea
  8. Hypotension (abnormally low blood pressure)
  9. Acute stress disorder
  10. Blood alkaline phosphatase increased

60+:

  1. Injury
  2. Pneumonia
  3. Fear
  4. Glycosylated haemoglobin increased
  5. Haematocrit decreased
  6. Multi-organ failure (multisystem organ failure)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)
  9. Stress
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 33.33%
  2. Nuclear Magnetic Resonance Imaging Brain: 5 people, 27.78%
  3. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 4 people, 22.22%
  4. Neuralgia (pain in one or more nerves): 4 people, 22.22%
  5. Nausea And Vomiting: 4 people, 22.22%
  6. Anaesthesia: 4 people, 22.22%
  7. Indigestion: 4 people, 22.22%
  8. Bradycardia (abnormally slow heart action): 4 people, 22.22%
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 22.22%
  10. Headache (pain in head): 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Lidocaine and Plendil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lidocaine and Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lidocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidocaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plendil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine and felodipine (the active ingredients of Lidocaine and Plendil, respectively), and Lidocaine and Plendil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: